RemSleep Holdings (RMSL) Interest Coverage Ratio Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 56.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.98% |
| Sep 30, 2025 | 31.33% |
| Jun 30, 2025 | 48.03% |
| Mar 31, 2025 | -24.56% |
| Dec 31, 2024 | -187.52% |
| Sep 30, 2024 | -106.98% |
| Jun 30, 2024 | -151.72% |
| Mar 31, 2024 | -98.70% |
| Jun 30, 2023 | -435.18% |
| Mar 31, 2023 | -339.05% |
| Dec 31, 2022 | -386.80% |
| Sep 30, 2022 | -296.70% |
| Jun 30, 2022 | 39.67% |
| Mar 31, 2022 | 42.80% |
| Dec 31, 2021 | -26.07% |
| Sep 30, 2021 | 85.61% |
| Jun 30, 2021 | 89.53% |
| Mar 31, 2021 | 86.59% |
| Dec 31, 2020 | 78.45% |
| Sep 30, 2020 | 86.83% |
| Jun 30, 2020 | 84.84% |
| Dec 31, 2017 | -495.28% |